title: Neuraminidase inhibitors for influenza complications.
authors.affiliation: Centre for Research in Evidence Based Practice, Bond University, Robina, QLD 4226, Australia. Electronic address: cdelmar@bond.edu.au.
authors.forename: Chris
authors.initials: C
authors.lastname: Del Mar
authors.affiliation: University of Maryland School of Pharmacy, MD, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Doshi
authors.affiliation: Japan Institute of Pharmacovigilance, Osaka, Japan.
authors.forename: Rokuro
authors.initials: R
authors.lastname: Hama
authors.affiliation: School of population health, University of Queensland, QLD, Australia.
authors.forename: Mark
authors.initials: M
authors.lastname: Jones
authors.affiliation: Cochrane Collaboration, Rome, Italy.
authors.forename: Tom
authors.initials: T
authors.lastname: Jefferson
authors.affiliation: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
authors.forename: Carl
authors.initials: C
authors.lastname: Heneghan
authors.affiliation: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
authors.forename: Igho
authors.initials: I
authors.lastname: Onakpoya
authors.affiliation: Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Howick
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D009439:Neuraminidase / Q000037:antagonists & inhibitors*
chemical_list: D000998:Antiviral Agents; D009439:Neuraminidase